Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial (Q51572280)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 1997

edit

Language	Label	Description	Also known as
English	Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial	scientific article published in December 1997

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9428832

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/9428832

title

Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9428832

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/9428832

main subject

type 2 diabetes

0 references

placebo

1 reference

based on heuristic

inferred from title

metformin

1 reference

based on heuristic

inferred from title

author name string

Garber AJ

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9428832

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/9428832

Duncan TG

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9428832

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/9428832

Goodman AM

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9428832

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/9428832

Mills DJ

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9428832

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/9428832

Rohlf JL

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9428832

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/9428832

language of work or name

English

0 references

publication date

1 December 1997

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9428832

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/9428832

published in

American Journal of Medicine

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9428832

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/9428832

volume

103

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9428832

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/9428832

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9428832

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/9428832

page(s)

491-497

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9428832

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/9428832

cites work

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

Cellular mechanism of action of metformin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

Biguanides and NIDDM

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

The comparison of several dose levels with a zero dose control

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

What is the benefit of increasing the sulfonylurea dose?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

Metformin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900254-4

retrieved

7 January 2021

Identifiers

DOI

10.1016/S0002-9343(97)00254-4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9428832

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/9428832

PubMed publication ID

9428832

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9428832

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/9428832

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51572280&oldid=2277394544"